Expression of the neural RNA-binding protein Musashi1 in human gliomas
✍ Scribed by Masahiro Toda; Yukihiko Iizuka; Wangjie Yu; Takao Imai; Eiji Ikeda; Kazunari Yoshida; Takeshi Kawase; Yutaka Kawakami; Hideyuki Okano; Keiichi Uyemura
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 690 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0894-1491
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Tumor cells arising from a particular tissue may exhibit the same gene expression patterns as their precursor cells. To test this proposition, we have analyzed the expression of a neural RNA‐binding protein, Musashi1, in primary human central nervous system (CNS) tumors. In rodents, Musashi1 is expressed predominantly in proliferating multipotent neural precursor cells, but not in newly generated postmitotic neurons. The expression of Musashi1 is downregulated with the successive progression of neurogenesis. In normal adult human tissues, we detected low levels of Musashi1 expression in brain and testis by RT‐PCR analysis. In an RNA panel of 32 cancer tissues and cell lines, elevated expression of Musashi1 was seen in all five malignant gliomas studied, in contrast to the slight expression seen in other tumor cells, including those in several melanomas and a prostate cancer. Western blot analysis showed strong Musashi1 expression in malignant gliomas compared with nonneoplastic brain tissue. Glioblastomas, the most malignant form of glioma, showed higher Musashi1 expression than less malignant gliomas by immunohistochemical analysis. Tumors with strong Musashi1 expression tended to have high proliferative activity. Thus, the expression of Musashi1 correlated with the grade of the malignancy and proliferative activity in gliomas. These results suggest that primary CNS tumors may share gene expression patterns with primitive, undifferentiated CNS cells and that Musashi1 may be a useful marker for the diagnosis of CNS tumors. GLIA 34:1–7, 2001. © 2001 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
BC200 RNA is a 200-nucleotide-long non-messenger RNA that is selectively expressed in the primate nervous system, where it has been identified in somatodendritic domains of a subset of neurons. BC200 RNA is not normally expressed in non-neuronal somatic cells; it has been shown, however, to be expre
## Abstract HuR is a ligand for nuclear mRNAs containing adenylate‐uridylate‐rich (ARE) elements in the 3′‐untranslated region. Once bound to the mRNA, HuR is recognized by adapter proteins that then facilitate nuclear export of the complex. In the cytosol, HuR is thought to function to control sta
## Abstract The use of spontaneously occurring mouse models has proved to be a valuable tool throughout the years to delineate the signals required for nervous system development. This is especially true in the field of myelin biology, with a large number of different models available. The __quakin
## Abstract Angiotensin II exerts its cardiovascular effects mainly through the activation of AT~1~ receptors. These receptors can be regulated at a post‐transcriptional level, that is through the modulation of the mRNA stability. This regulation usually involves proteins which are able to bind the
## Abstract The oncofetal CRD‐BP/IMP1 RNA binding protein regulates posttranscriptionally a handful of RNA transcripts, implicated in cell adhesion and invadopodia formation and was recently identified as a target of the β‐catenin/Tcf transcription factor that is constitutively activated in colorec